Highlights
KLSE: DPHARMA (7148)       DUOPHARMA BIOTECH BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
1.33   0.00 (0.00%)  0.00 - 0.00  0
Analyze this stock with MQ Trader system

Financials


Market Cap: 905 Million

Market Cap 905 Million
NOSH 680 Million

Latest Audited Result:  31-Dec-2018

Latest Audited Result: 31-Dec-2018
Announcement Date 29-Apr-2019
Next Audited Result: 31-Dec-2019
Est. Ann. Date: 29-Apr-2020
Est. Ann. Due Date: 28-Jun-2020

Latest Quarter:  30-Jun-2019 [#2]

Latest Quarter: 30-Jun-2019 [#2]
Announcement Date 30-Aug-2019
Next Quarter: 30-Sep-2019
Est. Ann. Date: 28-Nov-2019
Est. Ann. Due Date: 29-Nov-2019
QoQ | YoY   -3.80%  |    34.60%

Annual (Unaudited) ( EPS: 7.00, P/E: 18.99 )

Revenue | NP to SH 498,722  |  47,641
RPS | P/RPS 73.33 Cent  |  1.81
EPS | P/E | EY 7.00 Cent  |  18.99  |  5.27%
DPS | DY | Payout % 5.35 Cent  |  4.02%  |  76.41%
NAPS | P/NAPS 0.71  |  1.87
YoY   12.12%
NP Margin | ROE 9.55%  |  9.86%
F.Y. | Ann. Date 31-Dec-2018  |  18-Feb-2019

T4Q Result ( EPS: 8.09, P/E: 16.44 )

Revenue | NP to SH 537,324  |  55,036
RPS | P/RPS 79.01 Cent  |  1.68
EPS | P/E | EY 8.09 Cent  |  16.44  |  6.08%
DPS | DY | Payout % 4.87 Cent  |  3.66%  |  60.13%
NAPS | P/NAPS 0.74  |  1.80
QoQ | YoY   6.95%  |    23.97%
NP Margin | ROE 10.24%  |  10.94%
F.Y. | Ann. Date 30-Jun-2019  |  30-Aug-2019

Annualized Result ( EPS: 8.35, P/E: 15.94 )

Revenue | NP to SH 591,704  |  56,762
RPS | P/RPS 87.00 Cent  |  1.53
EPS | P/E | EY 8.35 Cent  |  15.94  |  6.28%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -1.90%  |    35.24%
NP Margin | ROE 9.59%  |  11.28%
F.Y. | Ann. Date 30-Jun-2019  |  30-Aug-2019


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2019 30-Aug-2019 30-Jun-2019 2 145,466 18,316 13,916 13,916 6,618 503,029 47.56% 9.57% 2.77% 661,881 21.98 21.39 2.07 2.05 1.00 0.97 0.7600 0.74   -3.80%   34.60% 28-Jun-2019 1.37 6.23 65.16 1.80 1.53% 0.73% 30-Aug-2019 1.41 6.42 67.06 1.86 1.49% 0.71%
31-Dec-2019 21-May-2019 31-Mar-2019 1 150,386 18,786 14,465 14,465 - 496,410 - % 9.62% 2.91% 661,881 22.72 22.11 2.19 2.13 0.00 0.00 0.7500 0.73   0.67%   34.16% 29-Mar-2019 1.28 5.63 58.57 1.71 1.71% 0.00% 21-May-2019 1.36 5.99 62.23 1.81 1.61% 0.00%
31-Dec-2018 18-Feb-2019 31-Dec-2018 4 115,634 17,658 14,369 14,369 26,475 483,173 184.25% 12.43% 2.97% 661,881 17.47 17.00 2.17 2.11 4.00 3.89 0.7300 0.71   16.95%   21.05% 31-Dec-2018 0.95 5.44 43.76 1.30 2.29% 4.21% 18-Feb-2019 1.03 5.90 47.45 1.41 2.11% 3.88%
31-Dec-2018 28-Nov-2018 30-Sep-2018 3 125,838 15,838 12,286 12,286 - 501,487 - % 9.76% 2.45% 659,852 19.07 18.50 1.86 1.81 0.00 0.00 0.7600 0.74   18.83%   7.72% 28-Sep-2018 1.23 6.45 66.06 1.62 1.51% 0.00% 28-Nov-2018 1.07 5.61 57.47 1.41 1.74% 0.00%
31-Dec-2018 26-Nov-2018 30-Jun-2018 2 123,991 12,915 10,339 10,339 4,199 209,983 40.62% 8.34% 4.92% 279,978 44.29 18.23 1.59 1.52 1.50 0.62 0.7500 0.31   -4.11%   7.11% 29-Jun-2018 1.30 2.94 35.20 1.73 2.84% 1.15% 26-Nov-2018 1.08 2.44 29.25 1.44 3.42% 1.39%
31-Dec-2018 28-May-2018 31-Mar-2018 1 133,259 13,255 10,647 10,782 - 206,429 - % 7.99% 5.22% 278,959 47.77 19.59 3.82 1.59 0.00 0.00 0.7400 0.30   -9.17%   25.11% 30-Mar-2018 2.80 5.86 72.44 3.78 1.38% 0.00% 28-May-2018 3.35 7.01 86.67 4.53 1.15% 0.00%
31-Dec-2017 28-Feb-2018 31-Dec-2017 4 112,253 12,825 11,768 11,870 16,737 479,809 141.01% 10.48% 2.47% 278,959 40.24 16.51 4.22 1.75 6.00 2.46 1.7200 0.71   4.08%   40.84% 29-Dec-2017 2.53 6.29 59.46 1.47 1.68% 2.37% 28-Feb-2018 2.97 7.38 69.80 1.73 1.43% 2.02%
31-Dec-2017 17-Nov-2017 30-Sep-2017 3 115,379 14,207 11,127 11,405 - 474,230 - % 9.64% 2.40% 278,959 41.36 16.96 3.99 1.68 0.00 0.00 1.7000 0.70   18.15%   79.86% 29-Sep-2017 2.20 5.32 53.81 1.29 1.86% 0.00% 17-Nov-2017 2.20 5.32 53.81 1.29 1.86% 0.00%
31-Dec-2017 25-Aug-2017 30-Jun-2017 2 117,049 12,642 9,641 9,653 6,973 463,071 72.25% 8.24% 2.08% 278,959 41.96 17.21 3.46 1.42 2.50 1.03 1.6600 0.68   12.01%   114.37% 30-Jun-2017 2.25 5.36 65.02 1.36 1.54% 1.11% 25-Aug-2017 2.03 4.84 58.66 1.22 1.70% 1.23%
31-Dec-2017 22-May-2017 31-Mar-2017 1 120,994 11,176 8,618 8,618 - 463,071 - % 7.12% 1.86% 278,959 43.37 17.79 3.43 1.27 0.00 0.00 1.6600 0.68   2.25%   9.88% 31-Mar-2017 2.31 5.33 74.77 1.39 1.34% 0.00% 22-May-2017 2.32 5.35 75.10 1.40 1.33% 0.00%
31-Dec-2016 24-Feb-2017 31-Dec-2016 4 74,033 6,299 8,831 8,428 11,158 454,703 132.40% 11.93% 1.85% 278,959 26.54 10.89 3.41 1.24 4.00 1.64 1.6300 0.67   32.91%   -45.04% 30-Dec-2016 1.98 7.46 65.54 1.21 1.53% 2.02% 24-Feb-2017 2.23 8.40 73.81 1.37 1.35% 1.79%
31-Dec-2016 21-Nov-2016 30-Sep-2016 3 80,302 7,516 6,226 6,341 - 451,913 - % 7.75% 1.40% 278,959 28.79 11.81 2.23 0.93 0.00 0.00 1.6200 0.66   40.82%   -26.46% 30-Sep-2016 2.06 7.16 90.63 1.27 1.10% 0.00% 21-Nov-2016 2.10 7.30 92.39 1.30 1.08% 0.00%
31-Dec-2016 22-Aug-2016 30-Jun-2016 2 79,135 7,723 3,941 4,503 6,973 446,334 154.87% 4.98% 1.01% 278,959 28.37 11.64 1.41 0.66 2.50 1.03 1.6000 0.66   -42.59%   -23.00% 30-Jun-2016 2.04 7.19 126.38 1.28 0.79% 1.23% 22-Aug-2016 2.14 7.54 132.57 1.34 0.75% 1.17%
31-Dec-2016 18-May-2016 31-Mar-2016 1 79,470 9,941 7,828 7,843 - 457,492 - % 9.85% 1.71% 278,959 28.49 11.68 2.81 1.15 0.00 0.00 1.6400 0.67   -48.86%   -12.55% 31-Mar-2016 2.55 8.95 90.70 1.55 1.10% 0.00% 18-May-2016 2.40 8.42 85.36 1.46 1.17% 0.00%
31-Dec-2015 23-Feb-2016 31-Dec-2015 4 89,401 17,529 17,529 15,335 9,172 270,177 59.82% 19.61% 5.68% 166,776 53.61 13.15 9.19 2.25 5.50 1.35 1.6200 0.40   77.84%   37.92% 31-Dec-2015 2.62 4.89 28.49 1.62 3.51% 2.10% 23-Feb-2016 2.61 4.87 28.39 1.61 3.52% 2.11%
31-Dec-2015 24-Nov-2015 30-Sep-2015 3 79,372 11,621 8,623 8,623 - 268,509 - % 10.86% 3.21% 166,776 47.59 11.67 5.17 1.27 0.00 0.00 1.6100 0.39   47.45%   -0.68% 30-Sep-2015 2.72 5.72 52.61 1.69 1.90% 0.00% 24-Nov-2015 2.70 5.67 52.22 1.68 1.91% 0.00%
31-Dec-2015 25-Aug-2015 30-Jun-2015 2 56,308 8,407 5,848 5,848 5,582 189,815 95.47% 10.39% 3.08% 139,570 40.34 8.28 4.19 0.86 4.00 0.82 1.3600 0.28   -34.80%   -22.16% 30-Jun-2015 2.65 6.57 63.25 1.95 1.58% 1.51% 25-Aug-2015 2.40 5.95 57.28 1.76 1.75% 1.67%
31-Dec-2015 18-May-2015 31-Mar-2015 1 45,599 12,198 8,969 8,969 - 205,045 - % 19.67% 4.37% 139,486 32.69 6.70 6.43 1.32 0.00 0.00 1.4700 0.30   -19.34%   7.22% 31-Mar-2015 3.88 11.87 60.34 2.64 1.66% 0.00% 18-May-2015 3.90 11.93 60.65 2.65 1.65% 0.00%
31-Dec-2014 24-Feb-2015 31-Dec-2014 4 51,024 13,921 13,921 11,119 20,128 192,951 181.02% 27.28% 5.76% 138,813 36.76 7.50 8.01 1.63 14.50 2.96 1.3900 0.28   28.07%   19.39% 31-Dec-2014 2.50 6.80 31.21 1.80 3.20% 5.80% 24-Feb-2015 2.92 7.94 36.45 2.10 2.74% 4.97%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 44,819 11,287 8,682 8,682 - 187,531 - % 19.37% 4.63% 138,912 32.26 6.59 6.25 1.28 0.00 0.00 1.3500 0.28   15.56%   27.94% 30-Sep-2014 3.17 9.83 50.72 2.35 1.97% 0.00% 21-Nov-2014 3.01 9.33 48.16 2.23 2.08% 0.00%
31-Dec-2014 26-Aug-2014 30-Jun-2014 2 40,623 10,107 7,513 7,513 5,554 179,145 73.94% 18.49% 4.19% 138,872 29.25 5.97 5.41 1.10 4.00 0.82 1.2900 0.26   -10.19%   -29.71% 30-Jun-2014 2.97 10.15 54.90 2.30 1.82% 1.35% 26-Aug-2014 3.37 11.52 62.29 2.61 1.61% 1.19%
31-Dec-2014 20-May-2014 31-Mar-2014 1 40,495 11,175 8,365 8,365 - 190,050 - % 20.66% 4.40% 138,723 29.19 5.95 6.03 1.23 0.00 0.00 1.3700 0.28   -10.18%   24.87% 31-Mar-2014 3.03 10.38 50.25 2.21 1.99% 0.00% 20-May-2014 3.09 10.59 51.24 2.26 1.95% 0.00%
31-Dec-2013 26-Feb-2014 31-Dec-2013 4 45,734 9,160 9,313 9,313 18,737 181,818 201.19% 20.36% 5.12% 138,792 32.95 6.72 6.71 1.37 13.50 2.76 1.3100 0.27   37.24%   55.27% 31-Dec-2013 2.58 7.83 38.45 1.97 2.60% 5.23% 26-Feb-2014 2.60 7.89 38.75 1.98 2.58% 5.19%
31-Dec-2013 19-Nov-2013 30-Sep-2013 3 40,845 9,054 6,786 6,786 - 179,017 - % 16.61% 3.79% 138,773 29.43 6.01 4.89 1.00 0.00 0.00 1.2900 0.26   -36.51%   5.34% 30-Sep-2013 2.55 8.66 52.15 1.98 1.92% 0.00% 19-Nov-2013 2.56 8.70 52.35 1.98 1.91% 0.00%
31-Dec-2013 28-Aug-2013 30-Jun-2013 2 37,988 13,007 10,689 10,689 5,552 187,404 51.95% 28.14% 5.70% 138,818 27.37 5.59 7.70 1.57 4.00 0.82 1.3500 0.28   59.56%   55.66% 28-Jun-2013 2.38 8.70 30.91 1.76 3.24% 1.68% 28-Aug-2013 2.44 8.92 31.69 1.81 3.16% 1.64%
31-Dec-2013 27-May-2013 31-Mar-2013 1 37,837 8,956 6,699 6,699 - 176,143 - % 17.70% 3.80% 138,695 27.28 5.56 4.83 0.98 0.00 0.00 1.2700 0.26   11.69%   -0.13% 29-Mar-2013 2.23 8.17 46.17 1.76 2.17% 0.00% 27-May-2013 2.51 9.20 51.97 1.98 1.92% 0.00%
31-Dec-2012 25-Feb-2013 31-Dec-2012 4 35,378 9,000 5,998 5,998 14,576 169,359 243.02% 16.95% 3.54% 138,819 25.48 5.20 4.32 0.88 10.50 2.14 1.2200 0.25   -6.89%   -5.23% 31-Dec-2012 2.13 8.36 49.30 1.75 2.03% 4.93% 25-Feb-2013 2.17 8.51 50.22 1.78 1.99% 4.84%
31-Dec-2012 23-Nov-2012 30-Sep-2012 3 29,521 8,391 6,442 6,442 - 167,991 - % 21.82% 3.83% 138,836 21.26 4.34 4.64 0.95 0.00 0.00 1.2100 0.25   -6.19%   -14.35% 28-Sep-2012 2.36 11.10 50.86 1.95 1.97% 0.00% 23-Nov-2012 2.28 10.72 49.14 1.88 2.04% 0.00%
31-Dec-2012 16-Aug-2012 30-Jun-2012 2 34,355 9,037 6,867 6,867 4,855 162,310 70.71% 19.99% 4.23% 138,727 24.76 5.05 4.95 1.01 3.50 0.71 1.1700 0.24   2.37%   -0.94% 29-Jun-2012 2.23 9.00 45.05 1.91 2.22% 1.57% 16-Aug-2012 2.38 9.61 48.08 2.03 2.08% 1.47%
31-Dec-2012 17-May-2012 31-Mar-2012 1 36,057 8,869 6,708 6,708 - 170,824 - % 18.60% 3.93% 138,881 25.96 5.30 4.83 0.99 0.00 0.00 1.2300 0.25   5.99%   13.23% 30-Mar-2012 2.40 9.24 49.69 1.95 2.01% 0.00% 17-May-2012 2.38 9.17 49.28 1.93 2.03% 0.00%
31-Dec-2011 22-Feb-2012 31-Dec-2011 4 33,036 7,836 6,329 6,329 20,125 163,776 317.98% 19.16% 3.86% 138,793 23.80 4.86 4.56 0.93 14.50 2.96 1.1800 0.24   -15.85%   -26.53% 30-Dec-2011 2.02 8.49 44.30 1.71 2.26% 7.18% 22-Feb-2012 2.12 8.91 46.49 1.80 2.15% 6.84%
31-Dec-2011 21-Nov-2011 30-Sep-2011 3 36,767 9,726 7,521 7,521 - 162,353 - % 20.46% 4.63% 138,763 26.50 5.41 5.42 1.11 0.00 0.00 1.1700 0.24   8.50%   -1.29% 30-Sep-2011 2.10 7.93 38.75 1.79 2.58% 0.00% 21-Nov-2011 2.10 7.93 38.75 1.79 2.58% 0.00%
31-Dec-2011 18-Aug-2011 30-Jun-2011 2 35,345 9,292 6,932 6,932 4,862 154,198 70.14% 19.61% 4.50% 138,917 25.44 5.20 4.99 1.02 3.50 0.71 1.1100 0.23   17.02%   -5.12% 30-Jun-2011 2.34 9.20 46.89 2.11 2.13% 1.50% 18-Aug-2011 2.22 8.73 44.49 2.00 2.25% 1.58%
31-Dec-2011 25-May-2011 31-Mar-2011 1 32,984 7,875 5,924 5,924 - 162,320 - % 17.96% 3.65% 138,735 23.77 4.85 4.27 0.87 0.00 0.00 1.1700 0.24   -31.23%   15.48% 31-Mar-2011 2.35 9.88 55.04 2.01 1.82% 0.00% 25-May-2011 2.57 10.81 60.19 2.20 1.66% 0.00%
31-Dec-2010 23-Feb-2011 31-Dec-2010 4 32,195 8,607 8,614 8,614 152 156,744 1.77% 26.76% 5.50% 138,711 23.21 4.73 6.21 1.27 0.11 0.02 1.1300 0.23   13.06%   9.82% 30-Dec-2010 2.39 10.30 38.49 2.12 2.60% 0.05% 23-Feb-2011 2.45 10.56 39.45 2.17 2.53% 0.04%
31-Dec-2010 26-Nov-2010 30-Sep-2010 3 34,464 10,221 7,619 7,619 - 148,494 - % 22.11% 5.13% 138,779 24.83 5.07 5.49 1.12 0.00 0.00 1.0700 0.22   4.28%   9.96% 30-Sep-2010 2.44 9.83 44.44 2.28 2.25% 0.00% 26-Nov-2010 2.38 9.58 43.35 2.22 2.31% 0.00%
31-Dec-2010 24-Aug-2010 30-Jun-2010 2 35,982 9,790 7,306 7,306 6,250 140,286 85.55% 20.30% 5.21% 138,897 25.91 5.29 5.26 1.07 4.50 0.92 1.0100 0.21   42.42%   -13.87% 30-Jun-2010 2.45 9.46 46.58 2.43 2.15% 1.84% 24-Aug-2010 2.45 9.46 46.58 2.43 2.15% 1.84%
31-Dec-2010 25-May-2010 31-Mar-2010 1 28,796 6,792 5,130 5,130 - 146,967 - % 17.81% 3.49% 138,648 20.77 4.23 3.70 0.75 0.00 0.00 1.0600 0.22   -34.60%   -26.48% 31-Mar-2010 2.40 11.56 64.86 2.26 1.54% 0.00% 25-May-2010 2.38 11.46 64.32 2.25 1.55% 0.00%
31-Dec-2009 23-Feb-2010 31-Dec-2009 4 29,850 8,610 7,844 7,844 16,659 142,996 212.39% 26.28% 5.49% 138,831 21.50 4.39 5.65 1.15 12.00 2.45 1.0300 0.21   13.21%   123.03% 31-Dec-2009 2.40 11.16 42.48 2.33 2.35% 5.00% 23-Feb-2010 2.33 10.84 41.24 2.26 2.42% 5.15%
31-Dec-2009 20-Nov-2009 30-Sep-2009 3 32,188 9,268 6,929 6,929 - 143,023 - % 21.53% 4.84% 138,857 23.18 4.73 4.99 1.02 0.00 0.00 1.0300 0.21   -18.32%   -19.36% 30-Sep-2009 2.58 11.13 51.70 2.50 1.93% 0.00% 20-Nov-2009 2.49 10.74 49.90 2.42 2.00% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock with T+7 trading account. Find out more.
  4 people like this.
 
k3nthiew Push harder please....
28/03/2019 4:20 PM
yapchehhak Slow and steady win the race
29/03/2019 7:31 AM
chshzhd good counter,keep for long term..
29/03/2019 12:35 PM
Manekineko Agree, waiting for next entry point when drop.
03/04/2019 4:38 PM
Dakewlest Any idea for next entry point?
04/04/2019 10:30 AM
Dakewlest Anyone know when are we getting the 4sen dividend?
08/04/2019 10:34 AM
chshzhd last year div ex june
08/04/2019 11:05 AM
VSOLAR Sailang Margin All In Punter thinking this counter not bad too
08/04/2019 9:35 PM
Dakewlest I bought some this week... may add some more later.
10/04/2019 3:50 PM
Investeye Disposed some to take profit..
10/04/2019 4:54 PM
Investeye Disposed most of the lots as EPF is gradually disposed this counter..
Wait for next wave..
23/04/2019 9:56 AM
Dakewlest Epf acquired last week.
23/04/2019 12:28 PM
Investeye Disposed all DPharma and bank on Pharma. In general, EPF disposed more than acquired..
23/04/2019 4:40 PM
keyin Why EPF do so
23/04/2019 5:37 PM
VinLol123 This counter suitable for long term..
27/04/2019 3:31 PM
YAPSS Day 81 of Fundamental Daily, YAPSS will be covering Duopharma Biotech Berhad's fundamental via a short animated video. I hope it helps and please enjoy the video, see ya! #YAPSS #FundamentalDaily #DuopharmaBiotechBerhad

Click the on the link to find out more: https://youtu.be/wKtLhzvZy_c
25/05/2019 9:28 AM
moneytrail Going for DRP and hold long term! Healthy sales!
22/06/2019 6:39 PM
factorrumour price has been flat for quite some time already, is it a good time to enter?
25/06/2019 4:08 PM
Ern Siah How to do the reinvestment?
26/06/2019 12:41 AM
NewbieTradingChannel Dpharma 7/7/2019 now it is on a symmetrical triangle ... breaking 1.3900 can target 1.440.
07/07/2019 1:25 PM
Jason bullish engulfing with volume, show time?
01/08/2019 4:22 PM
k3nthiew https://www.reuters.com/article/us-duopharma-btech-malaysia/malaysias-duopharma-talks-deals-with-trade-war-hit-chinese-firms-idUSKCN1UW0E4
06/08/2019 4:11 PM
k3nthiew KUALA LUMPUR (Reuters) - Duopharma Biotech (DUOP.KL), Malaysia’s largest generic drugmaker, is in talks with two Chinese consumer healthcare companies for expansion of their production base in Southeast Asia and a potential stake sale, its managing director said.

During an interview with Reuters, Duopharma Managing Director Leonard Ariff bin Abdul Shatar declined to name the companies as the discussions were ongoing. However, he said both “reasonably big” companies were listed in China with an annual revenue of more than $1 billion each.

The Chinese companies, one based in Shanghai and the other in Beijing, had asked Kuala Lumpur’s Duopharma if it would be able to contract-manufacture for them. They have also discussed buying a stake in Duopharma, Leonard said.

“They have manufacturing bases currently in China, supplying to the United States. These are guys whom I would not have expected to see in this part of the world, but for the trade war,” he said.

Duopharma, which has a market valuation of about $220 million, was open to a stake sale of up to 10% in the company, Leonard said, adding that if a deal was finalised, the Malaysian firm will apply to register with the U.S. Food and Drug Administration.

“There is a famous Malay saying: when two elephants fight, the ants die. But what we see here is absolutely the opposite. This has come as a bit of a surprise,” he said.

Dented by higher U.S. tariffs, Chinese companies are seeking partners to partly shift their supply chain to Southeast Asian countries such as Vietnam, Malaysia and Indonesia, analysts and Malaysian government officials said.

In the first quarter of 2019, Southeast Asia’s third-biggest economy attracted foreign investment of more than $7 billion – a 73% surge from a year earlier. The Malaysian government and its trade agencies are sending their representatives to China and other countries, organizing seminars and signing agreements of cooperation.

Late last month, the China ambassador to Malaysia confirmed the high level of Chinese interest in its traditional trade partner.
06/08/2019 4:12 PM
Coldman Very good news for stakeholder, hope it can be deal soon.
06/08/2019 4:50 PM
Jason Good fundamental and aggressive management. This counter is worth to hold for long term investment.
06/08/2019 5:20 PM
moneytrail No action yet. So difficult to bull doze pass 1.43. :(
07/08/2019 11:04 PM
Jason 1.43 been tested many times. Damn hard to breach.
08/08/2019 9:36 AM
Shootup what so good it is, gotta share profit out after the deal
09/08/2019 6:19 AM
Jason what happens to dpharma today?
21/08/2019 5:07 PM
kalofarmako Hello
22/08/2019 3:37 PM
Jason hope it can break the strong resistance at 1.43.
22/08/2019 4:25 PM
factorrumour only super good quarter result can help it push to all time high and new record
23/08/2019 12:07 AM
Jason finally it moves after consolidate for so long
23/08/2019 2:56 PM
Shootup All time high qr must be good
23/08/2019 3:14 PM
kalofarmako yeahh. i can see the movement there.
26/08/2019 10:45 AM
kalofarmako It's going up time to buy ! Come on gaiss.

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/221505.jsp
26/08/2019 10:52 AM
Jason quiet counter
27/08/2019 11:12 PM
kalofarmako Quiet but the price still okay hoo
28/08/2019 9:55 AM
kalofarmako Pharmaniaga’s focus on non-concession ops seen to boost profit

https://www.klsescreener.com/v2/news/view/572140
28/08/2019 9:59 AM
Jason among all the other healthcare counter, only this one is on uptrend. Phamaniage revenue and profit is inconsistent and poor cash flow, no way to compare to duopharma.
28/08/2019 11:54 AM
Jason dpharma rock today, achieving new high..
29/08/2019 4:07 PM
kalofarmako Morning!

Something good to read in the morning.

"High time to decide on concession issue"

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/222426.jsp
30/08/2019 9:10 AM
Jason boring dpharma
03/09/2019 9:00 PM
kalofarmako WOW!!

The positive long-term outlook for Pharmaniaga

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/223457.jsp
05/09/2019 1:09 PM
kalofarmako DHM explained that Pharmaniaga is only responsible for the logistics of supplying drugs to government health facilities, rather than the supply itself.

Check out here: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224313.jsp
11/09/2019 10:56 AM
rajachulan I had stopped buying any stock which dealing with gomen... many months ago... after i have seen how gomen play construction sector...

gdluck buying stock dealing with gomen...
11/09/2019 11:00 AM
kalofarmako “The big problem is price control, not Pharmaniaga,” says MyCC

Social activist Lim Mah Hui, one of the conductors of the MyCC study, said Pharmaniaga did not have a monopoly over supply but a virtual monopoly over logistics.

Check out: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224759.jsp
13/09/2019 9:52 AM
rajachulan no doubt... healthcare and insurance are two industries APAC to grow next few decade... however... if the govt !@#$%^&*()... then !@#$%^&*()
13/09/2019 10:07 AM
Jason drop like hell, this counter really need super long term investment
17/09/2019 2:01 PM
chshzhd buy..
17/09/2019 4:40 PM